Physician profile
Benjamin Caughlin
NPI 1972828283
$1,153.58
in general payments reported to CMS, 2019-2025
7 companies · $22.46 in 2025
The $22.46 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $108 · 2020: $28.35 · 2021: $622 · 2022: $147 · 2023: $48.47 · 2024: $177 · 2025: $22.46.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $248.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $247.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $777.69 | 2019-2024 | Dysport |
| Merz North America, INC. | $144.04 | 2021 | |
| Stryker Corporation | $106.36 | 2019-2021 | |
| Abbvie INC. | $48.47 | 2023 | |
| Solta Medical, A Division of Bausch Health US, LLC | $40.48 | 2022-2025 | Clear+Brilliant |
| Integra Lifesciences Corporation | $19.92 | 2024 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Allergan, INC. | $16.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Caughlin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.